watchman device

Ready for a deep dive into the intricate world of managing A-fibrillation? Here's your golden ticket! In our latest MedEvidence episode, Dr. Neil Sanghvi and Dr. Michael Koren peel back the layers to reveal the most effective therapies for this condition. We tackle the tough decisions, like choosing between anticoagulation and a left atrial closure device, and shed light on exciting research developments in the field. You'll get a swift education in the coagulation cascade, the Watchman device and the Champion trial, which compares the efficacy of anticoagulants and device implantation.

As we navigate further down the rabbit hole, we delve into the potential benefits of A-Fib ablation to manage symptoms, the indications for anticoagulants, and the impact of clinical research on therapy advancement. Prepare to be riveted as we discuss the transition off anticoagulants post-device placement and explore the role of genetics in A-fibrillation. We also touch upon the incorporation of artificial intelligence and other game-changing technologies to identify A-fibrillation and predict complications. We wrap up the episode with a candid discussion about the potential risks of ablation, mitigation strategies, and the irreplaceable value of follow-up care after A-Fib ablation. If you're looking for powerful insights and wisdom from the field of medicine, this episode of MedEvidence is a must-listen.

Recording Date April 20, 2023

Be a part of advancing science by participating in clinical research

Share with a friend. Rate, Review, and Subscribe to the MedEvidence! podcast to be notified when new episodes are released.

Follow us on Social Media:
Facebook
Instagram
Twitter
LinkedIn

Want to learn more checkout our entire library of podcasts, videos, articles and presentations at www.MedEvidence.com

Powered by ENCORE Research Group
Music: Storyblocks - Corporate Inspired

Thank you for listening!

Minimally invasive heart procedures like TAVR and MitraClip have made headlines in recent years. What makes these innovative approaches so remarkable? And what other advanced techniques are available to make heart surgery less traumatic while changing lives for the better?

Host, Dr. Jonathan Fialkow, deputy medical director and chief of cardiology at Baptist Health’s Miami Cardiac & Vascular Institute, (MCVI), and Dr. Ramon Quesada, medical director of interventional cardiology at MCVI, delve into the fascinating world of heart procedure innovations.

 Dr. Quesada was the first physician in Florida to perform a percutaneous mitral valve repair with MitraClip. He’s been a clinical investigator on multiple trials for coronary interventions and structural heart disease and a leader in developing minimally invasive techniques.